{
"id":"mk19_bb_en_s17",
"subspecialtyId":"en",
"title":"Primary Hyperaldosteronism",
"jsonContent":{
"type":"section",
"id":"mk19_bb_en_s17",
"title":{
"__html":"Primary Hyperaldosteronism"
},
"titleNode":{
"type":"section-title",
"hlId":"e4dadb",
"children":[
"Primary Hyperaldosteronism"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_en_s17_1",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"34c0b5",
"children":[
"Primary hyperaldosteronism is caused by aldosterone-producing adrenal adenomas (40%) or by bilateral adrenal hyperplasia. Testing indications are:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"0f067f",
"children":[
"untreated hypertension with sustained ",
{
"type":"abbreviation",
"title":"blood pressure",
"children":[
"BP"
]
},
" >150/100 mm Hg"
]
},
" ",
{
"type":"list-item",
"hlId":"abbc25",
"children":[
"resistant hypertension (>140/90 mm Hg) with three-drug therapy including a diuretic"
]
},
" ",
{
"type":"list-item",
"hlId":"1890f8",
"children":[
"hypertension and an incidentally discovered adrenal mass"
]
},
" ",
{
"type":"list-item",
"hlId":"983fb1",
"children":[
"hypertension associated with spontaneous or diuretic-induced hypokalemia"
]
},
" ",
{
"type":"list-item",
"hlId":"7ee271",
"children":[
"hypertension in the setting of a first-degree relative with primary aldosteronism"
]
},
" ",
{
"type":"list-item",
"hlId":"ed5ddb",
"children":[
"hypertension in the setting of family history of hypertension onset <40 years of age"
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_en_s17_2",
"title":{
"__html":"Testing"
},
"titleNode":{
"type":"section-title",
"hlId":"fa6a5a",
"children":[
"Testing"
]
},
"children":[
{
"type":"p",
"hlId":"ed6d51",
"children":[
"Evaluate patients using simultaneous measurements of plasma aldosterone and plasma renin activity. In patients taking an ",
{
"type":"abbreviation",
"title":"angiotensin-converting enzyme",
"children":[
"ACE"
]
},
" inhibitor or an ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"angiotensin receptor blocker",
"children":[
"ARB"
]
},
","
]
},
" a nonsuppressed plasma renin level rules out mineralocorticoid excess."
]
},
{
"type":"p",
"hlId":"a4ce0e",
"children":[
"A plasma aldosteroneâ€“plasma renin activity ratio >20, with a plasma aldosterone level >15 ng/dL, strongly suggests primary hyperaldosteronism. The diagnosis is confirmed by demonstrating nonsuppressibility of elevated plasma aldosterone in response to a high salt load given intravenously or orally."
]
},
{
"type":"p",
"hlId":"95757d",
"children":[
" ",
{
"type":"alert",
"children":[
"Testing can be done in patients receiving treatment with all antihypertensive agents except spironolactone and eplerenone, both of which antagonize the aldosterone receptor."
]
},
" "
]
},
{
"type":"p",
"hlId":"f6d13f",
"children":[
"After autonomous hyperaldosteronism is diagnosed, select CT of the adrenal glands. Adrenal vein sampling is needed before surgery to confirm the source of aldosterone secretion when imaging is unrevealing and to confirm lateralization when imaging demonstrates an adrenal adenoma."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"b5b298",
"children":[
"Almost 50% of patients with hyperaldosteronism do NOT have hypokalemia."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_en_s17_3",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"dda707",
"children":[
"Spironolactone or eplerenone is the treatment of choice for adrenal hyperplasia. Laparoscopic adrenalectomy is indicated for an aldosterone-producing adenoma."
]
}
]
}
]
},
"tablesContent":{
}
}